![Estela Rodriguez: Disparities in survival among patients with metastatic NSCLC via JNCI](https://oncodaily.com/pub/uploads/2024/06/Screenshot_9-6-2024_182615_academic.oup_.com_-e1717943205836.jpeg)
Estela Rodriguez: Disparities in survival among patients with metastatic NSCLC via JNCI
Estela Rodriguez shared a post on X:
“Racial and socioeconomic disparities in survival among patients with metastatic NSCLC via JNCI
N= 17,134 SEER real world data
No Racial disparities in outcomes of ICI but clear disparities in receipt of ICI.”
Read further.
Source: Estela Rodriguez/X
Dr. Estelamari (Estela) Rodriguez is an Associate Director of Community Outreach and Co-Lead Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is a board certified in medical oncology and hematology.
In the past, she was the Medical Director Thoracic Oncology at Mount Sinai Medical Center Miami Beach. Dr. Rodriguez has a special interest in the early detection of lung cancer and increasing access to clinical trials. She is a community leader and mentor to many women and minorities in medicine. Her passion is community engagement and empowering women to be advocates for their health and profession.